Company / Working Capital per Share
Mineralys Therapeutics, Inc. Working Capital per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.93
FY2024
5-year range
$3.93 / $20.27
FY2022-FY2024
Trend
-40.4%
vs FY2023
Sector context
#125 of 210
Health Care
What the data says
At $3.93, Mineralys Therapeutics, Inc.'s working capital per share ranks #125 of 210 in the Health Care sector. Declined from $20.27 to $3.93 over the past 2 years.
Based on SEC 10-K filings.
3.93 in FY2024.
Declined from $20.27 to $3.93 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 210 in Health CareTop 60% of 210This company $3.93 Sector average $146.86
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 40.4% year-over-year.
- Ranks #125 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.93 | -40.4% |
| FY2023 | $6.59 | -67.5% |
| FY2022 | $20.27 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026